Mohammed Er-rajy

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia

Mohamed El fadili, Mohammed Er-rajy, Mohammed Kara et al. · Pharmaceuticals · 2022 · 64 citations · Full text

Medicinal Chemistry, Aryl Methyl, Drug Target +15

Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation

Mohammed Er-rajy, Mohamed El fadili, Somdutt Mujwar et al. · Journal of Biomolecular Structure and Dynamics · 2023 · 51 citations · Full text

3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists

Mohamed El fadili, Mohammed Er-rajy, Hamada Imtara et al. · Processes · 2022 · 49 citations · Full text

Drug Target, Pain Medicine, Neuropathic Pain +22

2D-QSAR modeling, drug-likeness studies, ADMET prediction, and molecular docking for anti-lung cancer activity of 3-substituted-5-(phenylamino) indolone derivatives

Mohammed Er-rajy, Mohamed El fadili, Hanine Hadni et al. · Structural Chemistry · 2022 · 47 citations

Medicinal Chemistry, Biochemistry, Medicine +8

QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties

Mohamed El fadili, Mohammed Er-rajy, Hamada Imtara et al. · Heliyon · 2023 · 42 citations · Full text